{
  "docId": "019de075-da5f-7126-b0c8-5ad6b3fad507",
  "docSlug": "2367b4018d9bb2d1e01ea441f685753d",
  "documentTitle": "Neumora Therapeutics | IPO Presentation Deck | 32 slides",
  "authorId": "neumora-therapeutics",
  "authorName": "Neumora Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2023-09-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7794254,
  "pageNumber": 15,
  "pageCount": 32,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 16,
  "notes": "Includes qualitative expert testimonials regarding pricing and market access.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-da5f-7126-b0c8-5ad6b3fad507/15",
  "deckHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507",
  "deckJsonHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507.json",
  "deckAnchorHref": "/decks/019de075-da5f-7126-b0c8-5ad6b3fad507#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.75,
        "w": 0.55,
        "x": 0.02,
        "y": 0.18
      },
      "kind": "diagram",
      "text": "MDD patient funnel from 21M diagnosed to 3-5% net penetration",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cd318bfa-de26-475b-a8dd-2f231c3bdf2a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.96,
        "x": 0.02,
        "y": 0.85
      },
      "kind": "list",
      "text": "Upside drivers: Safer agent drives treatment seeking, Patients fast fail 1st line, Safer agent drives compliance, Inflation adjusted pricing",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c882773b-23dd-4186-ab2f-cf309cbae33b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.38,
        "x": 0.6,
        "y": 0.65
      },
      "kind": "quote",
      "text": "...is a combo of two products that exist; I would expect a pretty steep discount, for example 50-60% is going to be what it takes ... [navacaprant] is a lower discount since it is a unique MOA ... Executive, Magellan",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22c5b13e-ad70-4963-b108-d2bc701bb004",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.38,
        "x": 0.6,
        "y": 0.78
      },
      "kind": "quote",
      "text": "... 15-25% or up to 30% are reasonable discounts [for navacaprant] a few years after launch, given it's a new MoA as an antidepressant, that's a big benefit ... Pharmacy Director, Anthem BCBS OH",
      "attrs": null,
      "subkind": "testimonial",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4d16b7c2-a30b-4038-aa21-ba80513c8270",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.6,
        "y": 0.18
      },
      "kind": "table",
      "text": "Neuropsychology Pricing Catalogues",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1ab2f17-6c00-4995-8d97-d422772e78bf",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.96,
        "x": 0.02,
        "y": 0.02
      },
      "kind": "title",
      "text": "Navacaprant: MDD Market in U.S. Provides Potential Large Blockbuster Opportunity for Differentiated Product with Novel Mechanism of Action",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cbae2174-865f-4dc9-a490-84c5c104dda3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "market-segmentation-pyramid",
      "slug": null,
      "matchId": "1793b49e-bffc-4823-b5ac-6c29c9f74b1f",
      "evidence": "The patient funnel diagram segments the total addressable market into treated and line-of-therapy segments.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 15,
      "from": 15,
      "beatId": "71a39db9-74d4-4c7b-8ac8-ff73acc17ac3",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Market Sizing",
      "beatSlug": null,
      "evidence": "A slide estimating the large MDD patient population and potential upside for Navacaprant.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}